| Ticker: | LPCN |
| Current Price: | $1.71 |
| % Daily Change: | 5.56% |
| Volume (1,000s): | 214.11 |
| Average Volume (1,000s): | 89.31 |
| Market Cap (M): | $14.10 |
| 1/2/2024 Price: | $2.86 |
| Change Since Inception: | -40.21% |
Lipocine Inc.
675 Arapeen Drive
Suite 202
Salt Lake City, UT 84108
United States
Lipocine Inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products. The company develops drugs based on Hydroance, a drug delivery technology. It primarily focuses on developing oral versions of several hormones for use in men and women health. The company’s lipid-based technology platform offers non-invasive delivery solutions for small polar organics and macromolecules. It also offers custom drugs for pharmaceutical/biotechnology companies. Lipocine Inc. was founded in 1997 and is headquartered in Salt Lake City, Utah.